Mitsuhiro Yuasa presented his in-depth investment thesis on JIN (3046), Park 24 (4666) and Daiken Medical (7775) at Japan Investing Summit 2012.
About the instructor:
Mitsuhiro Yuasa founded Rheos Capital Works, a Tokyo-based investment firm specializing in small cap stocks, in 2003. Previously, Yuasa-san held positions at Rothschild Asset Management and Gartmore Asset Management. Yuasa-san has extensive experience in the analysis and management of emerging growth stock portfolios and long/short equity hedge funds, as well as deep knowledge of the Japanese and global asset management industry. Rheos’ clients include sovereign wealth funds and major Japanese corporate pension funds.
Members, log in below to access the full session.
Not a member?
Thank you for your interest. Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:
About The Author: MOI Global Editorial Team
The MOI Global Editorial Team, led by John Mihaljevic, CFA, includes community builders, event organizers, writers, editors, research associates, security analysts, and fanatical member support advocates. Our sole purpose is to serve the members of MOI Global as well as we possibly can in order to help them learn, invest intelligently, and build lifelong friendships with like-minded people.
Who is MOI Global? In recent years, The Manual of Ideas has expanded to become more than simply “the very best investing newsletter on the planet” (Mohnish Pabrai). We are now a thriving global community of intelligent investors, connected through great ideas, thought-provoking interviews, online conferences, live member events, and much more.
Members of MOI Global enjoy complimentary access to a growing array of resources and content related to the art of intelligent investing. Members also enjoy preferential access to selected offline events as well as exclusive access to other events hosted by MOI Global, including the Zurich Project Summit, the Latticework Conference, and Ideaweek.
More posts by MOI Global Editorial Team